OPSYNVI 10 mg/1
macitentan and tadalafil · TABLET, FILM COATED · Actelion Pharmaceuticals US, Inc.
OPSYNVI is a tablet, film coated containing macitentan and tadalafil at 10 mg/1, taken oral. Manufactured by Actelion Pharmaceuticals US, Inc..
Key Facts
- Brand Name
- OPSYNVI
- Generic Name
- macitentan and tadalafil
- NDC Code (Product)
66215-812- Manufacturer
- Actelion Pharmaceuticals US, Inc.
- Strength
- 10 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA218490
- Drug Class
- Endothelin Receptor Antagonist [EPC]; Phosphodiesterase 5 Inhibitor [EPC]
- Marketing Start
- 03/22/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is OPSYNVI used for?
OPSYNVI contains macitentan and tadalafil. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is OPSYNVI a controlled substance?
OPSYNVI is not classified as a controlled substance by the DEA.
What is the generic name for OPSYNVI?
The generic name for OPSYNVI is macitentan and tadalafil. There are no other listed brand versions of macitentan and tadalafil.
What is the NDC code for OPSYNVI 10 mg/1?
The NDC (National Drug Code) for OPSYNVI 10 mg/1 is 66215-812, listed by Actelion Pharmaceuticals US, Inc..
Other OPSYNVI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)